Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients.
Parisa AmirifarMahya MehrmohamadiMohammad Reza RanjouriSeyed Mohammad AkramiNima RezaeiAli SaberiReza YazdaniHassan AbolhassaniAsghar AghamohammadiPublished in: Journal of clinical immunology (2021)
Additional impact of certain variants, along with ATM mutations, may explain the heterogeneity in CSR defect phenotype among A-T patients. It can be concluded that genetic modulators play an important role in the course of A-T disease and its clinical severity.